Recombinant Human CDK7 Protein，His

CDK7 (Cyclin-Dependent Kinase 7) is a pivotal enzyme involved in the regulation of the cell cycle and transcriptional control, functioning at the intersection of these critical cellular processes. As a component of the complex containing cyclin H and MAT1A, CDK7 acts as a kinase for the transcriptional cofactor CDK-activating kinase (CAK), contributing to the phosphorylation of RNA polymerase II. This phosphorylation is essential for the transition from transcription initiation to elongation, making CDK7 a crucial player in gene expression regulation. Research into CDK7 has gained momentum due to its association with various cancers and its role in the maintenance of stemness in cancer cells. Given its integral role in transcription and cell cycle regulation, CDK7 is increasingly recognized as a promising therapeutic target. Inhibitors of CDK7 are being explored for their potential to not only halt tumor cell proliferation but also to induce differentiation in malignant cells. Additionally, studies have highlighted the enzyme's involvement in mediating responses to DNA damage and its potential effects on therapeutic resistance. As such, understanding CDK7’s structure, function, and regulatory mechanisms will not only deepen our comprehension of cell biology but also aid in the development of innovative cancer treatments. The examination of CDK7's interactions, post-translational modifications, and its broader impact on oncogenic signaling pathways is essential for elucidating its role in both normal physiology and disease states.